Clinical Trials Logo

Recurrent Aphthous Stomatitis clinical trials

View clinical trials related to Recurrent Aphthous Stomatitis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04385979 Completed - Clinical trials for Recurrent Aphthous Stomatitis

Curcumin and Nanocurcumin in Oral Aphthous Ulcer

Start date: July 15, 2018
Phase: N/A
Study type: Interventional

Recurrent aphthous ulcer is a painful inflammatory lesion with a high prevalence. Since the etiology is not clear, several strategies have been proposed to reduce pain and severity of its symptoms. Today, curcumin is considered as an herbal medicine with anti-inflammatory properties. Treatment or control of various inflammatory diseases has been proposed, but its low solubility in water has reduced bioavailability, while the use of nanoparticle pharmaceutical techniques has been able to solve these problems. Therefore, the aim of the present study was to evaluate the clinical efficacy of a new topical curcumin gel with nano-technology and compare it with 2% curcumin gel in patients with recurrent aphthous ulcers. This randomized clinical trial was performed on 48 patients assigned to two groups (nano-curcumin gel) and (curcumin gel). Before treatment, the size of the wound and VAS were measured. After intervention, the two variables were measured again on the fourth and seventh days , then the amount of improvement was quantitatively and qualitatively compared in the two groups and a significant level of less than 0.05 was considered.

NCT ID: NCT04265001 Completed - Clinical trials for Recurrent Aphthous Stomatitis

Topical Hyaluronic Acid and Recurrent Aphthous Stomatitis.

Start date: November 1, 2019
Phase: Phase 3
Study type: Interventional

This study was conducted to estimate the hypothesis that the topical hyaluronic acid mouthwash have no role in the treatment of recurrent aphthous stomatitis

NCT ID: NCT03690544 Completed - Clinical trials for Recurrent Aphthous Stomatitis

Apremilast for RAS

Start date: October 12, 2018
Phase: Phase 4
Study type: Interventional

Determination of treatment efficacy and safety of Apremilast in patients with RAS

NCT ID: NCT02920658 Completed - Oral Lichen Planus Clinical Trials

Topical "Non-Aromatic Very Rich in Steranes" (NAVS) Naphthalan for the Treatment of Oral Mucosal Diseases

Start date: December 2010
Phase: Phase 2
Study type: Interventional

This study evaluates the effectiveness of topical NAVS naphthalan in the treatment of oral lichen planus (OLP) and recurrent aphthous stomatitis (RAS). Half of participants with OLP and RAS will receive topical NAVS naphthalan in adhesive paste, while the other half will receive 0.05%-betamethasone dipropionate in adhesive paste. Our hypothesis is that NAVS could be efficient in the treatment of OLP and RAS, with effects comparable to that of topical steroids.

NCT ID: NCT01652625 Completed - Clinical trials for Recurrent Aphthous Stomatitis

Efficacy and Safety Study of Yunnan Baiyao on Minor Recurrent Aphthous Stomatitis

Start date: March 2010
Phase: Phase 2
Study type: Interventional

Recurrent aphthous stomatitis (RAS) is a common recurrent oral disorder with no curative treatment available to date. The challenge remains in patients that do develop drug resistance and/or secondary infection, although topical corticosteroids and antimicrobials are the first therapeutic choice. The aim of the study was to evaluate the efficacy and safety of an herbal extract of Yunnan Baiyao formulated in toothpaste as an alternative therapy for minor RAS. Yunnan Baiyao is a well-known traditional Chinese medicine, formulated in a powder or capsule form. It was initially and widely used in wounds for its anti-hemorrhagic hemostatic function, and further in gastrointestinal bleeding. Yunnan Baiyao powder has been generally applied on RAS among Chinese population. In this study, a randomized, double-blind, placebo-controlled clinical trial (from March 2010 to March 2011) was conducted on a cohort of 227 minor RAS patients. The toothpaste containing Yunnan Baiyao was used twice daily as part of the patient's routine oral hygiene for 5 days. An assessment of ulcerative size and pain was recorded on Day 0 (baseline), Day 3 and Day 5. Any noted adverse reactions were recorded.

NCT ID: NCT01501409 Completed - Clinical trials for Recurrent Aphthous Stomatitis

Effect of Sodium Lauryl Sulfate on Recurrent Aphthous Stomatitis

Start date: January 2010
Phase: N/A
Study type: Interventional

Sodium lauryl sulfate (SLS) is an anionic detergent that has been used as the major or sole surfactant in most dentifrices. But it is known to local irritating factor to oral mucosa and skin and results in many side effects. This study was to compare the effects of SLS-free dentifrice and SLS-containing dentifrice in patients with recurrent aphthous stomatitis (RAS).

NCT ID: NCT01122147 Completed - Clinical trials for Recurrent Aphthous Stomatitis

Clinical Evaluation of Fluid Extract of Chamomilla Tincture for Oral Aphthae

Start date: April 2010
Phase: Phase 1
Study type: Interventional

Recurrent aphthous stomatitis is a difficult to treat and quite common chronic inflammatory disease of the oral mucosa. This study evaluates the fluid extract from Chamomilla recutita's safety and effectiveness in treatment of aphthous stomatitis .

NCT ID: NCT00315679 Completed - Clinical trials for Recurrent Aphthous Stomatitis

A Trial of Pentoxifylline for the Treatment of Recurrent Aphthous Stomatitis

Start date: June 1996
Phase: N/A
Study type: Interventional

This is a randomized, double blind, placebo controlled trial of the use of pentoxifylline (oxpentifylline) for the treatment of recurrent mouth ulcers.

NCT ID: NCT00288769 Completed - Clinical trials for Recurrent Aphthous Stomatitis

Oral Vitamin B12 as Potential Treatment of Recurrent Aphthous Stomatitis

Start date: March 2006
Phase: N/A
Study type: Interventional

Background: Recurrent aphthous stomatitis is a common phenomenon in Primary Medicine.Frequency of the phenomenon can be as high as 25% of the general population and the recurrence of the problem can be up to 50%.Different approaches for treatment are described: treatment with various natural vitamins , local ointments , disinfectant agents for local treatment , local antibiotic ointments , NSAID, local cortisone-steroids , and even medication on the basis of immune-depressants of the immune system and systematic steroids . Methods: A double-blind study of daily administration of sublingual Vitamin B12 tablets manufactured by Solgar (each tablet containing 1000 mcg. of Vitamin B12) opposed to placebo tablets. Purpose of the research: To investigate the effect of Vitamin B12 on the frequency of recurrent canker sores of the mouth (RAS). Study hypothesis: Treatment with vitamin B12 will reduce the recurrence rate and will diminish the symptomatology of RAS episodes.